Global Seasonal Influenza Vaccine Market Insights and Forecast to 2026

Global Seasonal Influenza Vaccine Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Seasonal Influenza Vaccine Product Introduction
1.2 Market Segments
1.3 Key Seasonal Influenza Vaccine Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Type
1.4.2 Trivalent Influenza Vaccine
1.4.3 Quadrivalent Influenza Vaccine
1.4.4 Other
1.5 Market by Application
1.5.1 Global Seasonal Influenza Vaccine Market Size Growth Rate by Application
1.5.2 Children
1.5.3 Adults
1.5.4 Elderly
1.5.5 Pregnancy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Seasonal Influenza Vaccine Market Size, Estimates and Forecasts
2.1.1 Global Seasonal Influenza Vaccine Revenue 2015-2026
2.1.2 Global Seasonal Influenza Vaccine Sales 2015-2026
2.2 Global Seasonal Influenza Vaccine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Seasonal Influenza Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Seasonal Influenza Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Seasonal Influenza Vaccine Competitor Landscape by Players
3.1 Seasonal Influenza Vaccine Sales by Manufacturers
3.1.1 Seasonal Influenza Vaccine Sales by Manufacturers (2015-2020)
3.1.2 Seasonal Influenza Vaccine Sales Market Share by Manufacturers (2015-2020)
3.2 Seasonal Influenza Vaccine Revenue by Manufacturers
3.2.1 Seasonal Influenza Vaccine Revenue by Manufacturers (2015-2020)
3.2.2 Seasonal Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Seasonal Influenza Vaccine Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Seasonal Influenza Vaccine Revenue in 2019
3.2.5 Global Seasonal Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Seasonal Influenza Vaccine Price by Manufacturers
3.4 Seasonal Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Seasonal Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Seasonal Influenza Vaccine Market Size by Type (2015-2020)
4.1.1 Global Seasonal Influenza Vaccine Sales by Type (2015-2020)
4.1.2 Global Seasonal Influenza Vaccine Revenue by Type (2015-2020)
4.1.3 Seasonal Influenza Vaccine Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Seasonal Influenza Vaccine Market Size Forecast by Type (2021-2026)
4.2.1 Global Seasonal Influenza Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Seasonal Influenza Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Seasonal Influenza Vaccine Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Seasonal Influenza Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Seasonal Influenza Vaccine Market Size by Application (2015-2020)
5.1.1 Global Seasonal Influenza Vaccine Sales by Application (2015-2020)
5.1.2 Global Seasonal Influenza Vaccine Revenue by Application (2015-2020)
5.1.3 Seasonal Influenza Vaccine Price by Application (2015-2020)
5.2 Seasonal Influenza Vaccine Market Size Forecast by Application (2021-2026)
5.2.1 Global Seasonal Influenza Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Seasonal Influenza Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Seasonal Influenza Vaccine Price Forecast by Application (2021-2026)
6 North America
6.1 North America Seasonal Influenza Vaccine by Country
6.1.1 North America Seasonal Influenza Vaccine Sales by Country
6.1.2 North America Seasonal Influenza Vaccine Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Seasonal Influenza Vaccine Market Facts & Figures by Type
6.3 North America Seasonal Influenza Vaccine Market Facts & Figures by Application
7 Europe
7.1 Europe Seasonal Influenza Vaccine by Country
7.1.1 Europe Seasonal Influenza Vaccine Sales by Country
7.1.2 Europe Seasonal Influenza Vaccine Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Seasonal Influenza Vaccine Market Facts & Figures by Type
7.3 Europe Seasonal Influenza Vaccine Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Seasonal Influenza Vaccine by Region
8.1.1 Asia Pacific Seasonal Influenza Vaccine Sales by Region
8.1.2 Asia Pacific Seasonal Influenza Vaccine Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Seasonal Influenza Vaccine Market Facts & Figures by Type
8.3 Asia Pacific Seasonal Influenza Vaccine Market Facts & Figures by Application
9 Latin America
9.1 Latin America Seasonal Influenza Vaccine by Country
9.1.1 Latin America Seasonal Influenza Vaccine Sales by Country
9.1.2 Latin America Seasonal Influenza Vaccine Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Seasonal Influenza Vaccine Market Facts & Figures by Type
9.3 Central & South America Seasonal Influenza Vaccine Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Seasonal Influenza Vaccine by Country
10.1.1 Middle East and Africa Seasonal Influenza Vaccine Sales by Country
10.1.2 Middle East and Africa Seasonal Influenza Vaccine Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Seasonal Influenza Vaccine Market Facts & Figures by Type
10.3 Middle East and Africa Seasonal Influenza Vaccine Market Facts & Figures by Application
11 Company Profiles
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Seasonal Influenza Vaccine Products Offered
11.1.5 GSK Related Developments
11.2 Sinovac
11.2.1 Sinovac Corporation Information
11.2.2 Sinovac Description and Business Overview
11.2.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sinovac Seasonal Influenza Vaccine Products Offered
11.2.5 Sinovac Related Developments
11.3 Changsheng
11.3.1 Changsheng Corporation Information
11.3.2 Changsheng Description and Business Overview
11.3.3 Changsheng Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Changsheng Seasonal Influenza Vaccine Products Offered
11.3.5 Changsheng Related Developments
11.4 CCBIO
11.4.1 CCBIO Corporation Information
11.4.2 CCBIO Description and Business Overview
11.4.3 CCBIO Sales, Revenue and Gross Margin (2015-2020)
11.4.4 CCBIO Seasonal Influenza Vaccine Products Offered
11.4.5 CCBIO Related Developments
11.5 Aleph Biomedical
11.5.1 Aleph Biomedical Corporation Information
11.5.2 Aleph Biomedical Description and Business Overview
11.5.3 Aleph Biomedical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Aleph Biomedical Seasonal Influenza Vaccine Products Offered
11.5.5 Aleph Biomedical Related Developments
11.6 Sanofi
11.6.1 Sanofi Corporation Information
11.6.2 Sanofi Description and Business Overview
11.6.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sanofi Seasonal Influenza Vaccine Products Offered
11.6.5 Sanofi Related Developments
11.7 Lanzhou Institute Of Biological Product
11.7.1 Lanzhou Institute Of Biological Product Corporation Information
11.7.2 Lanzhou Institute Of Biological Product Description and Business Overview
11.7.3 Lanzhou Institute Of Biological Product Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Products Offered
11.7.5 Lanzhou Institute Of Biological Product Related Developments
11.8 Siobp
11.8.1 Siobp Corporation Information
11.8.2 Siobp Description and Business Overview
11.8.3 Siobp Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Siobp Seasonal Influenza Vaccine Products Offered
11.8.5 Siobp Related Developments
11.9 Hualan Bio
11.9.1 Hualan Bio Corporation Information
11.9.2 Hualan Bio Description and Business Overview
11.9.3 Hualan Bio Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hualan Bio Seasonal Influenza Vaccine Products Offered
11.9.5 Hualan Bio Related Developments
11.10 Tianyuan Bio-Pharma
11.10.1 Tianyuan Bio-Pharma Corporation Information
11.10.2 Tianyuan Bio-Pharma Description and Business Overview
11.10.3 Tianyuan Bio-Pharma Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Tianyuan Bio-Pharma Seasonal Influenza Vaccine Products Offered
11.10.5 Tianyuan Bio-Pharma Related Developments
11.1 GSK
11.1.1 GSK Corporation Information
11.1.2 GSK Description and Business Overview
11.1.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.1.4 GSK Seasonal Influenza Vaccine Products Offered
11.1.5 GSK Related Developments
11.12 Hissen
11.12.1 Hissen Corporation Information
11.12.2 Hissen Description and Business Overview
11.12.3 Hissen Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Hissen Products Offered
11.12.5 Hissen Related Developments
11.13 Abbott
11.13.1 Abbott Corporation Information
11.13.2 Abbott Description and Business Overview
11.13.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Abbott Products Offered
11.13.5 Abbott Related Developments
11.14 Novartis
11.14.1 Novartis Corporation Information
11.14.2 Novartis Description and Business Overview
11.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Novartis Products Offered
11.14.5 Novartis Related Developments
11.15 Tasly&Jenner
11.15.1 Tasly&Jenner Corporation Information
11.15.2 Tasly&Jenner Description and Business Overview
11.15.3 Tasly&Jenner Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Tasly&Jenner Products Offered
11.15.5 Tasly&Jenner Related Developments
11.16 Tiantan
11.16.1 Tiantan Corporation Information
11.16.2 Tiantan Description and Business Overview
11.16.3 Tiantan Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Tiantan Products Offered
11.16.5 Tiantan Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Seasonal Influenza Vaccine Market Estimates and Projections by Region
12.1.1 Global Seasonal Influenza Vaccine Sales Forecast by Regions 2021-2026
12.1.2 Global Seasonal Influenza Vaccine Revenue Forecast by Regions 2021-2026
12.2 North America Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
12.2.1 North America: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
12.2.2 North America: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
12.2.3 North America: Seasonal Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.3 Europe Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
12.3.1 Europe: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
12.3.2 Europe: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
12.3.3 Europe: Seasonal Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Seasonal Influenza Vaccine Market Size Forecast by Region (2021-2026)
12.5 Latin America Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
12.5.1 Latin America: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
12.5.2 Latin America: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
12.5.3 Latin America: Seasonal Influenza Vaccine Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Seasonal Influenza Vaccine Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Seasonal Influenza Vaccine Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Seasonal Influenza Vaccine Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Seasonal Influenza Vaccine Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Seasonal Influenza Vaccine Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Seasonal Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Seasonal Influenza Vaccine Market Segments
Table 2. Ranking of Global Top Seasonal Influenza Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Seasonal Influenza Vaccine Market Size Growth Rate by Type 2020-2026 (K Doses) & (US$ Million)
Table 4. Major Manufacturers of Trivalent Influenza Vaccine
Table 5. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 6. Major Manufacturers of Other
Table 7. Global Seasonal Influenza Vaccine Market Size Growth Rate by Application 2020-2026 (K Doses)
Table 8. Global Seasonal Influenza Vaccine Market Size by Region (K Doses) & (US$ Million): 2020 VS 2026
Table 9. Global Seasonal Influenza Vaccine Sales by Regions 2015-2020 (K Doses)
Table 10. Global Seasonal Influenza Vaccine Sales Market Share by Regions (2015-2020)
Table 11. Global Seasonal Influenza Vaccine Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Seasonal Influenza Vaccine Sales by Manufacturers (2015-2020) (K Doses)
Table 13. Global Seasonal Influenza Vaccine Sales Share by Manufacturers (2015-2020)
Table 14. Global Seasonal Influenza Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Seasonal Influenza Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Influenza Vaccine as of 2019)
Table 16. Seasonal Influenza Vaccine Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Seasonal Influenza Vaccine Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Seasonal Influenza Vaccine Price (2015-2020) (USD/Dose)
Table 19. Seasonal Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Seasonal Influenza Vaccine Product Type
Table 21. Date of International Manufacturers Enter into Seasonal Influenza Vaccine Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Seasonal Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 24. Global Seasonal Influenza Vaccine Sales Share by Type (2015-2020)
Table 25. Global Seasonal Influenza Vaccine Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Seasonal Influenza Vaccine Revenue Share by Type (2015-2020)
Table 27. Seasonal Influenza Vaccine Average Selling Price (ASP) by Type 2015-2020 (USD/Dose)
Table 28. Global Seasonal Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 29. Global Seasonal Influenza Vaccine Sales Share by Application (2015-2020)
Table 30. North America Seasonal Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 31. North America Seasonal Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 32. North America Seasonal Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Seasonal Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 34. North America Seasonal Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 35. North America Seasonal Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 36. North America Seasonal Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 37. North America Seasonal Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 38. Europe Seasonal Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 39. Europe Seasonal Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 40. Europe Seasonal Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Seasonal Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 42. Europe Seasonal Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 43. Europe Seasonal Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 44. Europe Seasonal Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 45. Europe Seasonal Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Seasonal Influenza Vaccine Sales by Region (2015-2020) (K Doses)
Table 47. Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Seasonal Influenza Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Seasonal Influenza Vaccine Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Seasonal Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 51. Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Seasonal Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 53. Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 54. Latin America Seasonal Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 55. Latin America Seasonal Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Seasonal Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Seasonal Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 58. Latin America Seasonal Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 59. Latin America Seasonal Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 60. Latin America Seasonal Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 61. Latin America Seasonal Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Seasonal Influenza Vaccine Sales by Country (2015-2020) (K Doses)
Table 63. Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Seasonal Influenza Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Seasonal Influenza Vaccine Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Seasonal Influenza Vaccine Sales by Type (2015-2020) (K Doses)
Table 67. Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Seasonal Influenza Vaccine Sales by Application (2015-2020) (K Doses)
Table 69. Middle East and Africa Seasonal Influenza Vaccine Sales Market Share by Application (2015-2020)
Table 70. GSK Corporation Information
Table 71. GSK Description and Major Businesses
Table 72. GSK Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 73. GSK Product
Table 74. GSK Recent Development
Table 75. Sinovac Corporation Information
Table 76. Sinovac Description and Major Businesses
Table 77. Sinovac Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 78. Sinovac Product
Table 79. Sinovac Recent Development
Table 80. Changsheng Corporation Information
Table 81. Changsheng Description and Major Businesses
Table 82. Changsheng Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 83. Changsheng Product
Table 84. Changsheng Recent Development
Table 85. CCBIO Corporation Information
Table 86. CCBIO Description and Major Businesses
Table 87. CCBIO Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 88. CCBIO Product
Table 89. CCBIO Recent Development
Table 90. Aleph Biomedical Corporation Information
Table 91. Aleph Biomedical Description and Major Businesses
Table 92. Aleph Biomedical Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 93. Aleph Biomedical Product
Table 94. Aleph Biomedical Recent Development
Table 95. Sanofi Corporation Information
Table 96. Sanofi Description and Major Businesses
Table 97. Sanofi Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 98. Sanofi Product
Table 99. Sanofi Recent Development
Table 100. Lanzhou Institute Of Biological Product Corporation Information
Table 101. Lanzhou Institute Of Biological Product Description and Major Businesses
Table 102. Lanzhou Institute Of Biological Product Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 103. Lanzhou Institute Of Biological Product Product
Table 104. Lanzhou Institute Of Biological Product Recent Development
Table 105. Siobp Corporation Information
Table 106. Siobp Description and Major Businesses
Table 107. Siobp Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 108. Siobp Product
Table 109. Siobp Recent Development
Table 110. Hualan Bio Corporation Information
Table 111. Hualan Bio Description and Major Businesses
Table 112. Hualan Bio Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 113. Hualan Bio Product
Table 114. Hualan Bio Recent Development
Table 115. Tianyuan Bio-Pharma Corporation Information
Table 116. Tianyuan Bio-Pharma Description and Major Businesses
Table 117. Tianyuan Bio-Pharma Seasonal Influenza Vaccine Production (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 118. Tianyuan Bio-Pharma Product
Table 119. Tianyuan Bio-Pharma Recent Development
Table 120. Vaxtec Corporation Information
Table 121. Vaxtec Description and Major Businesses
Table 122. Vaxtec Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 123. Vaxtec Product
Table 124. Vaxtec Recent Development
Table 125. Hissen Corporation Information
Table 126. Hissen Description and Major Businesses
Table 127. Hissen Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 128. Hissen Product
Table 129. Hissen Recent Development
Table 130. Abbott Corporation Information
Table 131. Abbott Description and Major Businesses
Table 132. Abbott Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 133. Abbott Product
Table 134. Abbott Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Major Businesses
Table 137. Novartis Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 138. Novartis Product
Table 139. Novartis Recent Development
Table 140. Tasly&Jenner Corporation Information
Table 141. Tasly&Jenner Description and Major Businesses
Table 142. Tasly&Jenner Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 143. Tasly&Jenner Product
Table 144. Tasly&Jenner Recent Development
Table 145. Tiantan Corporation Information
Table 146. Tiantan Description and Major Businesses
Table 147. Tiantan Seasonal Influenza Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2015-2020)
Table 148. Tiantan Product
Table 149. Tiantan Recent Development
Table 150. Global Seasonal Influenza Vaccine Sales Forecast by Regions (2021-2026) (K Doses)
Table 151. Global Seasonal Influenza Vaccine Sales Market Share Forecast by Regions (2021-2026)
Table 152. Global Seasonal Influenza Vaccine Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 153. Global Seasonal Influenza Vaccine Revenue Market Share Forecast by Regions (2021-2026)
Table 154. North America: Seasonal Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 155. North America: Seasonal Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 156. Europe: Seasonal Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 157. Europe: Seasonal Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 158. Asia Pacific: Seasonal Influenza Vaccine Sales Forecast by Region (2021-2026) (K Doses)
Table 159. Asia Pacific: Seasonal Influenza Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 160. Latin America: Seasonal Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 161. Latin America: Seasonal Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 162. Middle East and Africa: Seasonal Influenza Vaccine Sales Forecast by Country (2021-2026) (K Doses)
Table 163. Middle East and Africa: Seasonal Influenza Vaccine Revenue Forecast by Country (2021-2026) (US$ Million)
Table 164. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 165. Key Challenges
Table 166. Market Risks
Table 167. Main Points Interviewed from Key Seasonal Influenza Vaccine Players
Table 168. Seasonal Influenza Vaccine Customers List
Table 169. Seasonal Influenza Vaccine Distributors List
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Seasonal Influenza Vaccine Product Picture
Figure 2. Global Seasonal Influenza Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Trivalent Influenza Vaccine Product Picture
Figure 4. Quadrivalent Influenza Vaccine Product Picture
Figure 5. Other Product Picture
Figure 6. Global Seasonal Influenza Vaccine Sales Market Share by Application in 2020 & 2026
Figure 7. Children
Figure 8. Adults
Figure 9. Elderly
Figure 10. Pregnancy
Figure 11. Seasonal Influenza Vaccine Report Years Considered
Figure 12. Global Seasonal Influenza Vaccine Market Size 2015-2026 (US$ Million)
Figure 13. Global Seasonal Influenza Vaccine Sales 2015-2026 (K Doses)
Figure 14. Global Seasonal Influenza Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Seasonal Influenza Vaccine Sales Market Share by Region (2015-2020)
Figure 16. Global Seasonal Influenza Vaccine Sales Market Share by Region in 2019
Figure 17. Global Seasonal Influenza Vaccine Revenue Market Share by Region (2015-2020)
Figure 18. Global Seasonal Influenza Vaccine Revenue Market Share by Region in 2019
Figure 19. Global Seasonal Influenza Vaccine Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Seasonal Influenza Vaccine Revenue in 2019
Figure 21. Seasonal Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Seasonal Influenza Vaccine Sales Market Share by Type (2015-2020)
Figure 23. Global Seasonal Influenza Vaccine Sales Market Share by Type in 2019
Figure 24. Global Seasonal Influenza Vaccine Revenue Market Share by Type (2015-2020)
Figure 25. Global Seasonal Influenza Vaccine Revenue Market Share by Type in 2019
Figure 26. Global Seasonal Influenza Vaccine Market Share by Price Range (2015-2020)
Figure 27. Global Seasonal Influenza Vaccine Sales Market Share by Application (2015-2020)
Figure 28. Global Seasonal Influenza Vaccine Sales Market Share by Application in 2019
Figure 29. Global Seasonal Influenza Vaccine Revenue Market Share by Application (2015-2020)
Figure 30. Global Seasonal Influenza Vaccine Revenue Market Share by Application in 2019
Figure 31. North America Seasonal Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 32. North America Seasonal Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Seasonal Influenza Vaccine Sales Market Share by Country in 2019
Figure 34. North America Seasonal Influenza Vaccine Revenue Market Share by Country in 2019
Figure 35. U.S. Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 36. U.S. Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 38. Canada Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Seasonal Influenza Vaccine Market Share by Type in 2019
Figure 40. North America Seasonal Influenza Vaccine Market Share by Application in 2019
Figure 41. Europe Seasonal Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 42. Europe Seasonal Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Seasonal Influenza Vaccine Sales Market Share by Country in 2019
Figure 44. Europe Seasonal Influenza Vaccine Revenue Market Share by Country in 2019
Figure 45. Germany Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 46. Germany Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 48. France Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 50. U.K. Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 52. Italy Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 54. Russia Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Seasonal Influenza Vaccine Market Share by Type in 2019
Figure 56. Europe Seasonal Influenza Vaccine Market Share by Application in 2019
Figure 57. Asia Pacific Seasonal Influenza Vaccine Sales Growth Rate 2015-2020 (K Doses)
Figure 58. Asia Pacific Seasonal Influenza Vaccine Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Seasonal Influenza Vaccine Sales Market Share by Region in 2019
Figure 60. Asia Pacific Seasonal Influenza Vaccine Revenue Market Share by Region in 2019
Figure 61. China Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 62. China Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 64. Japan Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 66. South Korea Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 68. India Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 70. Australia Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 72. Taiwan Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 74. Indonesia Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 76. Thailand Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Seasonal Influenza Vaccine Sales Growth Rate (2015-2020) (K Doses)
Figure 78. Malaysia Seasonal Influenza Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Seasonal Influenza Vaccine Sales Growth Rate (2015-2020

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs